7 important parameters to choose the right Tissue Processor - second run

• Report this article

Meximp Technologies

Meximp Technologies

Published Feb 18, 2021

+ Follow

In this educational webinar we will describe the top 7 factors you should consider to choose the right tissue processor, in accordance with your Lab needs, throughput and workflow.

04 Mar 2021

04:30 pm GMT+01

Read more

Help improve contributions

Mark contributions as unhelpful if you find them irrelevant or not valuable to the article. This feedback is private to you and won’t be shared publicly.

Got it

Contribution hidden for you

This feedback is never shared publicly, we’ll use it to show better contributions to everyone.

Undo

To view or add a comment, sign in

More articles by this author

No more previous content

• Agilent Announces Solutions Innovation Research Award to Dr. Jiangbin Ye

  May 5, 2023

• Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Muscle-Invasive Urothelial Carcinoma (MIUC)

  Oct 21, 2022

• Agilent’s Certified Pre-Owned Instruments Program Receives Environmental Award

  Jul 26, 2022

• Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Esophageal Squamous Cell Carcinoma

  Apr 7, 2022

• Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Muscle-Invasive Urothelial Carcinoma (MIUC)

  Apr 7, 2022

• The Innovators 2021

  Jan 21, 2022

• Agilent Names John Palma to Lead Global Medical Affairs Organization

  Nov 9, 2021

• Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction, or E

  Oct 22, 2021

• Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer

  Oct 22, 2021

• GE Healthcare Debuts MyoSPECT, A Next-Generation Nuclear Medicine Cardiology System That Gets to the Heart of Challenging Cardiovascular Cases

  Oct 4, 2021

No more next content

See all